Advertisement

Epidemiology and Management of Lassa Fever in the West African Sub-Region: Overcoming the Socio-cultural Challenges

  • Godsent Chichebem Isiguzo
  • Michael Onyebuchi Iroezindu
Chapter

Abstract

Lassa fever is a viral haemorrhagic fever endemic in West Africa, especially in: Guinea, Liberia, Nigeria and Sierra Leone. It is transmitted by the multimammate rat Mastomy natalensis, though additional rodent reservoir may contribute to infections. The virus was first identified in 1969 in the town of Lassa, North-East Nigeria from where it derived its name. Since then, several epidemics have occurred in endemic communities, including recent outbreaks with higher fatalities. There is evidence of expanding epidemiology within Africa, imported cases in Europe and North America, and potential for bioterrorism remains a global concern. In this Chapter, we describe the epidemiology and management of Lassa fever in the West African sub-region with a focus on overcoming the socio-cultural challenges. In memory of several healthcare workers who have lost their lives while providing care for Lassa fever patients, we start with a case vignette that describes the confusion and sadness the disease and its complications often bring. The chapter then goes on to discuss the epidemiology, virology, pathogenesis, clinical and laboratory characteristics of the disease with a highlight of the sociocultural challenges that perpetuate the epidemics of Lassa fever in most endemic communities 50 years after its characterisation. The chapter ends with suggestions on how to improve surveillance, prevention and control.

Keywords

Challenges Epidemiology Lassa fever Management Socio-cultural West Africa 

Notes

Dedication

This chapter is dedicated to the memory of Dr. Udenna Ama (1970–2009) and all health care workers in Africa who have lost their lives treating patients with Lassa fever.

References

  1. Ajayi, N. A., Nwigwe, C. G., Azuogu, B. N., Onyire, B. N., Nwonwu, E. U., Ogbonnaya, L. U., Onwe, F. I., Ekaete, T., Günther, S., & Ukwaja, K. N. (2013). Containing a Lassa fever epidemic in a resource-limited setting: Outbreak description and lessons learned from Abakaliki, Nigeria (January–March 2012). International Journal of Infectious Diseases, 17(11), e1011–e1016.PubMedCrossRefGoogle Scholar
  2. Allen, T., Murray, K. A., Zambrana-Torrelio, C., Morse, S. S., Rondinini, C., Di Marco, M., Breit, N., Olival, K. J., & Daszak, P. (2017). Global hotspots and correlates of emerging zoonotic diseases. Nature Communications, 8(1), 1124.PubMedPubMedCentralCrossRefGoogle Scholar
  3. Asogun, D. A., Adomeh, D. I., Ehimuan, J., Odia, I., Hass, M., Gabriel, M., Ölschläger, S., Becker-Ziaja, B., Folarin, O., & Phelan, E. (2012). Molecular diagnostics for Lassa fever at Irrua specialist teaching hospital, Nigeria: Lessons learnt from two years of laboratory operation. PLoS Neglected Tropical Diseases, 6(9), e1839.PubMedPubMedCentralCrossRefGoogle Scholar
  4. Atkin, S., Anaraki, S., Gothard, P., Walsh, A., Brown, D., Gopal, R., Hand, J., & Morgan, D. (2009). The first case of Lassa fever imported from Mali to the United Kingdom, February 2009. Euro Surveillance: Bulletin European sur les maladies transmissibles= European Communicable Disease Bulletin, 14(10), 19145.Google Scholar
  5. Bausch, D. G., Rollin, P. E., Demby, A. H., Coulibaly, M., Kanu, J., Conteh, A. S., Wagoner, K. D., McMullan, L. K., Bowen, M. D., & Peters, C. J. (2000). Diagnosis and clinical virology of Lassa fever as evaluated by enzyme-linked immunosorbent assay, indirect fluorescent-antibody test, and virus isolation. Journal of Clinical Microbiology, 38(7), 2670–2677.PubMedPubMedCentralGoogle Scholar
  6. Bausch, D. G., Demby, A. H., Coulibaly, M., Kanu, J., Goba, A., Bah, A., Condé, N., Wurtzel, H. L., Cavallaro, K. F., & Lloyd, E. (2001). Lassa fever in Guinea: I. Epidemiology of human disease and clinical observations. Vector Borne and Zoonotic Diseases, 1(4), 269–281.PubMedCrossRefGoogle Scholar
  7. Bennett, J. E., Dolin, R., & Blaser, M. J. (2014). Principles and practice of infectious diseases. London: Churchill Livingstone.Google Scholar
  8. Bowen, M. D., Peters, C. J., & Nichol, S. T. (1997). Phylogenetic analysis of the Arenaviridae: Patterns of virus evolution and evidence for cospeciation between arenaviruses and their rodent hosts. Molecular Phylogenetics and Evolution, 8(3), 301–316.PubMedCrossRefGoogle Scholar
  9. Branco, L. M., Boisen, M. L., Andersen, K. G., Grove, J. N., Moses, L. M., Muncy, I. J., Henderson, L. A., Schieffellin, J. S., Robinson, J. E., & Bangura, J. J. (2011a). Lassa hemorrhagic fever in a late term pregnancy from northern Sierra Leone with a positive maternal outcome: Case report. Virology Journal, 8(1), 404.PubMedPubMedCentralCrossRefGoogle Scholar
  10. Branco, L. M., Grove, J. N., Boisen, M. L., Shaffer, J. G., Goba, A., Fullah, M., Momoh, M., Grant, D. S., & Garry, R. F. (2011b). Emerging trends in Lassa fever: Redefining the role of immunoglobulin M and inflammation in diagnosing acute infection. Virology Journal, 8(1), 478.PubMedPubMedCentralCrossRefGoogle Scholar
  11. Brosh-Nissimov, T. (2016). Lassa fever: Another threat from West Africa. Disaster and Military Medicine, 2(1), 8.PubMedPubMedCentralCrossRefGoogle Scholar
  12. Buckley, S. M., & Casals, J. (1970). Lassa fever, a new virus disease of man from West Africa. The American Journal of Tropical Medicine and Hygiene, 19(4), 680–691.PubMedCrossRefGoogle Scholar
  13. Childs, J. E., Mackenzie, J. S., & Richt, J. A. (2007). Wildlife and emerging zoonotic diseases: The biology, circumstances and consequences of cross-species transmission (Vol. 315). Berlin: Springer.CrossRefGoogle Scholar
  14. Cummins, D., McCormick, J. B., Bennett, D., Samba, J. A., Farrar, B., Machin, S. J., & Fisher-Hoch, S. P. (1990). Acute sensorineural deafness in Lassa fever. JAMA, 264(16), 2093–2096.PubMedCrossRefGoogle Scholar
  15. Dahmane, A., van Griensven, J., Van Herp, M., Van den Bergh, R., Nzomukunda, Y., Prior, J., Alders, P., Jambai, A., & Zachariah, R. (2014). Constraints in the diagnosis and treatment of Lassa fever and the effect on mortality in hospitalized children and women with obstetric conditions in a rural district hospital in Sierra Leone. Transactions of the Royal Society of Tropical Medicine and Hygiene, 108(3), 126–132.PubMedPubMedCentralCrossRefGoogle Scholar
  16. Dudas, G., Carvalho, L. M., Bedford, T., Tatem, A. J., Baele, G., Faria, N. R., Park, D. J., Ladner, J. T., Arias, A., & Asogun, D. (2017). Virus genomes reveal factors that spread and sustained the Ebola epidemic. Nature, 544(7650), 309.PubMedPubMedCentralCrossRefGoogle Scholar
  17. Dzotsi, E. K., SA Ohene, F., Asiedu-Bekoe, J., Amankwa, B., Sarkodie, M. A., Thouphique, A. M., Ofei, A., Oduro, J., & Atitogo, D. (2012). The first cases of Lassa fever in Ghana. Ghana Medical Journal, 46(3), 166–170.PubMedPubMedCentralGoogle Scholar
  18. Ehichioya, D. U., Asogun, D. A., Ehimuan, J., Okokhere, P. O., Pahlmann, M., Ölschläger, S., Becker-Ziaja, B., Günther, S., & Omilabu, S. A. (2012). Hospital-based surveillance for Lassa fever in Edo state, Nigeria, 2005–2008. Tropical Medicine & International Health, 17(8), 1001–1004.CrossRefGoogle Scholar
  19. Fisher-Hoch, S. P., McCormick, J. B., Sasso, D., & Craven, R. B. (1988). Hematologic dysfunction in Lassa fever. Journal of Medical Virology, 26(2), 127–135.PubMedCrossRefGoogle Scholar
  20. Fisher-Hoch, S. P., Gborie, S., Parker, L., & Huggins, J. (1992). Unexpected adverse reactions during a clinical trial in rural West Africa. Antiviral Research, 19(2), 139–147.PubMedCrossRefGoogle Scholar
  21. Fisher-Hoch, S. P., Tomori, O., Nasidi, A., Perez-Oronoz, G. I., Fakile, Y., Hutwagner, L., & McCormick, J. B. (1995). Review of cases of nosocomial Lassa fever in Nigeria: The high price of poor medical practice. BMJ: British Medical Journal, 311(7009), 857–859.PubMedCrossRefGoogle Scholar
  22. Frame, J. D., Jr, J. M. B., Gocke, D. J., & Troup, J. M. (1970). Lassa fever, a new virus disease of man from West Africa. The American Journal of Tropical Medicine and Hygiene, 19(4), 670–676.PubMedCrossRefGoogle Scholar
  23. Frame, J. D., Yalley-Ogunro, J. E., & Hanson, A. P. (1984). Endemic Lassa fever in Liberia. V. Distribution of Lassa virus activity in Liberia: Hospital staff surveys. Transactions of the Royal Society of Tropical Medicine and Hygiene, 78(6), 761–763.PubMedCrossRefGoogle Scholar
  24. Grove, J. N., Branco, L. M., Boisen, M. L., Muncy, I. J., Henderson, L. A., Schieffellin, J. S., Robinson, J. E., Bangura, J. J., Fonnie, M., & Schoepp, R. J. (2011). Capacity building permitting comprehensive monitoring of a severe case of Lassa hemorrhagic fever in Sierra Leone with a positive outcome: Case report. Virology Journal, 8(1), 314.PubMedPubMedCentralCrossRefGoogle Scholar
  25. Günther, S., Emmerich, P., Laue, T., Kühle, O., Asper, M., Jung, A., Grewing, T., ter Meulen, J., & Schmitz, H. (2000). Imported Lassa fever in Germany: Molecular characterization of a new Lassa virus strain. Emerging Infectious Diseases, 6(5), 466–476.PubMedPubMedCentralCrossRefGoogle Scholar
  26. Holmes, G. P., McCormick, J. B., Trock, S. C., Chase, R. A., Lewis, S. M., Mason, C. A., Hall, P. A., Brammer, L. S., Perez-Oronoz, G. I., & McDonnell, M. K. (1990). Lassa fever in the United States. New England Journal of Medicine, 323(16), 1120–1123.PubMedCrossRefGoogle Scholar
  27. Ibekwe, T. S., Nwegbu, M. M., Asogun, D., Adomeh, D. I., & Okokhere, P. O. (2012). The sensitivity and specificity of Lassa virus IgM by ELISA as a screening tool at the early phase of Lassa fever infection. Nigerian Medical Journal: Journal of the Nigeria Medical Association, 53(4), 196–199.CrossRefGoogle Scholar
  28. Iroezindu, M. O., Unigwe, U. S., Okwara, C. C., Ozoh, G. A., Ndu, A. C., Ohanu, M. E., Nwoko, U. O., Okoroafor, U. W., Ejimudo, E., & Tobin, E. A. (2015). Lessons learnt from the management of a case of Lassa fever and follow-up of nosocomial primary contacts in Nigeria during Ebola virus disease outbreak in West Africa. Tropical Medicine & International Health, 20(11), 1424–1430.CrossRefGoogle Scholar
  29. Jahrling, P. B., Frame, J. D., Smith, S. B., & Monson, M. H. (1985). Endemic Lassa fever in Liberia. III. Characterization of Lassa virus isolates. Transactions of the Royal Society of Tropical Medicine and Hygiene, 79(3), 374–379.PubMedCrossRefGoogle Scholar
  30. Keenlyside, R. A., McCormick, J. B., Webb, P. A., Smith, E., Elliott, L., & Johnson, K. M. (1983). Case-control study of Mastomys natalensis and humans in Lassa virus-infected households in Sierra Leone. The American Journal of Tropical Medicine and Hygiene, 32(4), 829–837.PubMedCrossRefGoogle Scholar
  31. Kochhar, D. M. (1990). Effects of exposure to high concentrations of ribavirin in developing embryos. The Pediatric Infectious Disease Journal, 9(9), S88–S90.PubMedCrossRefGoogle Scholar
  32. Lukashevich, I. S., Clegg, J. C. S., & Sidibe, K. (1993). Lassa virus activity in Guinea: Distribution of human antiviral antibody defined using enzyme-linked immunosorbent assay with recombinant antigen. Journal of Medical Virology, 40(3), 210–217.PubMedCrossRefGoogle Scholar
  33. Macher, A. M., & Wolfe, M. S. (2006). Historical Lassa fever reports and 30-year clinical update. Emerging Infectious Diseases, 12(5), 835–837.PubMedPubMedCentralCrossRefGoogle Scholar
  34. McCarthy, M. (2002). USA moves quickly to push biodefence research. The Lancet, 360(9335), 732.CrossRefGoogle Scholar
  35. McCormick, J. B. (1987). Epidemiology and control of Lassa fever. Arenaviruses: Biology and Immunotherapy, 134, 69–78.CrossRefGoogle Scholar
  36. McCormick, J. B., & Fisher-Hoch, S. P. (2002). Lassa fever. In Arenaviruses I (pp. 75–109). Berlin: Springer-Verlag.Google Scholar
  37. McCormick, J. B., King, I. J., Webb, P. A., Johnson, K. M., O’Sullivan, R., Smith, E. S., Trippel, S., & Tong, T. C. (1987a). A case-control study of the clinical diagnosis and course of Lassa fever. Journal of Infectious Diseases, 155(3), 445–455.PubMedCrossRefGoogle Scholar
  38. McCormick, J. B., Webb, P. A., Krebs, J. W., Johnson, K. M., & Smith, E. S. (1987b). A prospective study of the epidemiology and ecology of Lassa fever. Journal of Infectious Diseases, 155(3), 437–444.PubMedCrossRefGoogle Scholar
  39. McCormink, J. B., King, Y. L., & Webb, P. A. (1986). Lassa fever: Effective therapy with ribavirin. The New England Journal of Medicine, 314, 2–26.Google Scholar
  40. McLay, L., Liang, Y., & Ly, H. (2014). Comparative analysis of disease pathogenesis and molecular mechanisms of New World and Old World arenavirus infections. Journal of General Virology, 95, 1):1–1)15.PubMedCrossRefGoogle Scholar
  41. Monath, T. P., Newhouse, V. F., Kemp, G. E., Setzer, H. W., & Cacciapuoti, A. (1974). Lassa virus isolation from Mastomys natalensis rodents during an epidemic in Sierra Leone. Science, 185(4147), 263–265.PubMedCrossRefGoogle Scholar
  42. Munster, V. J., Bausch, D. G., de Wit, E., Fischer, R., Kobinger, G., Muñoz-Fontela, C., Olson, S. H., Seifert, S. N., Sprecher, A., & Ntoumi, F. (2018). Outbreaks in a rapidly changing Central Africa – Lessons from Ebola. New England Journal of Medicine, 379, 1198–1201.PubMedCrossRefGoogle Scholar
  43. Ogbu, O., Ajuluchukwu, E., & Uneke, C. J. (2007). Lassa fever in west African sub-region: An overview. Journal of Vector-Borne Diseases, 44(1), 1–11.PubMedGoogle Scholar
  44. Ojosipe, D. (2017, August 27). Nigeria: Lassa fever kills 68, 718 cases recorded. Leadership. Accessed 28 Aug 2017. http://leadership.ng/2017/08/22/lassa-fever-kills-68-718-cases-recorded/
  45. Ölschläger, S., & Flatz, L. (2013). Vaccination strategies against highly pathogenic arenaviruses: The next steps toward clinical trials. PLoS Pathogens, 9(4), e1003212.PubMedPubMedCentralCrossRefGoogle Scholar
  46. Potapov, P., Hansen, M. C., Laestadius, L., Turubanova, S., Yaroshenko, A., Thies, C., Smith, W., Zhuravleva, I., Komarova, A., & Minnemeyer, S. (2017). The last frontiers of wilderness: Tracking loss of intact forest landscapes from 2000 to 2013. Science Advances, 3(1), e1600821.PubMedPubMedCentralCrossRefGoogle Scholar
  47. Richmond, J. K., & Baglole, D. J. (2003). Lassa fever: Epidemiology, clinical features, and social consequences. BMJ: British Medical Journal, 327(7426), 1271.PubMedCrossRefGoogle Scholar
  48. Ruo, S. L., Mitchell, S. W., Kiley, M. P., Roumillat, L. F., Fisher-Hoch, S. P., & McCormick, J. B. (1991). Antigenic relatedness between arenaviruses defined at the epitope level by monoclonal antibodies. Journal of General Virology, 72(3), 549–555.PubMedCrossRefGoogle Scholar
  49. Safronetz, D., Lopez, J. E., Sogoba, N., Traore, S. F., Raffel, S. J., Fischer, E. R., Ebihara, H., Branco, L., Garry, R. F., & Schwan, T. G. (2010). Detection of Lassa virus, Mali. Emerging Infectious Diseases, 16(7), 1123.PubMedPubMedCentralCrossRefGoogle Scholar
  50. Salazar-Bravo, J., Ruedas, L. A., & Yates, T. L. (2002). Mammalian reservoirs of arenaviruses. In Arenaviruses I (pp. 25–63). Berlin: Springer.CrossRefGoogle Scholar
  51. Shaffer, J. G., Grant, D. S., Schieffelin, J. S., Boisen, M. L., Goba, A., Hartnett, J. N., Levy, D. C., Yenni, R. E., Moses, L. M., & Fullah, M. (2014). Lassa fever in post-conflict Sierra Leone. PLoS Neglected Tropical Diseases, 8(3), e2748.PubMedPubMedCentralCrossRefGoogle Scholar
  52. Sogoba, N., Feldmann, H., & Safronetz, D. (2012). Lassa fever in West Africa: Evidence for an expanded region of endemicity. Zoonoses and Public Health, 59(s2), 43–47.PubMedCrossRefGoogle Scholar
  53. Ter Meulen, J., Lukashevich, I., Sidibe, K., Inapogui, A., Marx, M., Dorlemann, A., Yansane, M. L., Koulemou, K., Chang-Claude, J., & Schmitz, H. (1996). Hunting of peridomestic rodents and consumption of their meat as possible risk factors for rodent-to-human transmission of Lassa virus in the Republic of Guinea. The American Journal of Tropical Medicine and Hygiene, 55(6), 661–666.PubMedCrossRefGoogle Scholar
  54. The organization, World Health. (2017). Lassa fever-Nigeria. In Factsheet. Geneva: World Health Organization (WHO).Google Scholar
  55. Tomori, O., Fabiyi, A., Sorungbe, A., Smith, A., & McCormick, J. B. (1988). Viral hemorrhagic fever antibodies in Nigerian populations. The American Journal of Tropical Medicine and Hygiene, 38(2), 407–410.PubMedCrossRefGoogle Scholar
  56. Unigwe, U. S., Iroezindu, M. O., Umenzekwe, C. C., Chima, E. I., & Isiguzo, G. C., (2016, November 25–27). Knowledge, attitude and practices of medical officers in south-east Nigeria regarding Lassa fever management. In Annual general scientific conference of the Nigerian infectious diseases society. Abuja Nigeria.Google Scholar
  57. WHO. (2017). Lassa fever factsheet. Geneva: World Health Organization.Google Scholar
  58. Wilson, M. E. (1995). Infectious diseases: An ecological perspective. BMJ: British Medical Journal, 311(7021), 1681.PubMedCrossRefGoogle Scholar
  59. Wulff, H., Bruce M, M. I., Hamner, D. B., & Johnson, K. M. (1977). Isolation of an arenavirus closely related to Lassa virus from Mastomys natalensis in South-east Africa. Bulletin of the World Health Organization, 55(4), 441.PubMedPubMedCentralGoogle Scholar
  60. Wulff, H., Lange, J. V., & Webb, P. A. (1978). Interrelationships among arenaviruses measured by indirect immunofluorescence. Intervirology, 9(6), 344–350.CrossRefGoogle Scholar
  61. Yun, N. E., & Walker, D. H. (2012). Pathogenesis of Lassa fever. Viruses, 4(10), 2031–2048.PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Godsent Chichebem Isiguzo
    • 1
    • 2
  • Michael Onyebuchi Iroezindu
    • 3
    • 4
  1. 1.Department of MedicineFederal Teaching Hospital AbakalikiEbonyi StateNigeria
  2. 2.Department of Medicine, Faculty of Health SciencesUniversity of Cape TownCape TownSouth Africa
  3. 3.College of MedicineUniversity of NigeriaEnuguNigeria
  4. 4.Department of Internal MedicineUniversity of Nigeria Teaching HospitalEnuguNigeria

Personalised recommendations